Delivery Order SPE2DB22D2206-SPE2DB24FEY53
Award Date 1/5/24
Potential Completion Date 1/29/24
Potential Value $35K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML medical products. The contract, valued at $192,762.90, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract is a delivery order type with a firm fixed price pricing structure, and has an ultimate completion date of March 25, 2025....
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a pharmaceutical product. The contract has a ceiling value of $93,652.38 and an ultimate completion date of July 30, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency, on July 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a pharmaceutical product. The contract has a ceiling value of $52,571.70 and a period of performance extending until May 29, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $46,826.19, is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty medication, with a completion date of September 10, 2024. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This is a federal contract award to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $93,628.70 and a period of performance through August 5, 2024. It is a firm fixed-price delivery order for the pharmaceutical product ULTOMIRIS 300 MG/3 ML VIAL 3ML. AmerisourceBergen is a major pharmaceutical distributor that specializes in supplying medical products to federal government agencies, particularly within military and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $93,652.38 firm fixed-price delivery order is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a comprehensive...
- This is a $17,523.90 firm fixed price delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the procurement of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML. The contract has an ultimate completion date of April 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,835.28 firm fixed-price delivery order is for the supply of ULTOMIRIS 300 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen, a for-profit organization, is the prime contractor and there is no indication of set-aside...
- This federal contract award, valued at $96,889.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ultomiris, a 1,100 mg/11 ml specialty drug vial, with a performance period through January 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a delivery order under a $999,999,999 Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 1,100 mg/11 ml vials of the drug ULTOMIRIS, with a ceiling value of $46,826.19. The contract has a period of performance through November 12, 2024. The order does not have a set-aside designation, indicating it was awarded through...